Cefazolin Sodium Injectable Recalled Nationwide for Temperature Abuse
McKesson Medical-Surgical recalled Cefazolin Sodium injectable (39 cases nationwide) due to temperature abuse during manufacturing that may compromise product sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves temperature abuse of a sterile injectable pharmaceutical product. Temperature deviation is a risk-of-harm situation that could compromise product sterility and integrity. No illnesses or injuries have been reported in the source material.
Plain-English summary
McKesson Medical-Surgical Inc. has recalled Cefazolin Sodium for injection USP (2g, 50mL duplex container) manufactured by B. Braun Medical Inc. The recall involves 39 cases distributed nationwide in the United States.
The recall was initiated due to cGMP deviations involving temperature abuse during manufacturing. Temperature exposure of a sterile injectable product may compromise product sterility and integrity.
McKesson Medical-Surgical reports that it cannot identify the specific lot numbers received by individual customers. Each recall notification letter includes the distribution date and dates when affected product may have been shipped to the customer.
Healthcare facilities that received this product should consult the information provided in their recall notification letter for details on affected shipments.
The recalled product
- Product
- CEFAZOLIN SODIUM (CEFAZOLIN SODIUM)
- Brand
- CEFAZOLIN SODIUM
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Sterile Injectables
- Affected units
- 39
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same brand · CEFAZOLIN SODIUM
- HighCefazolin Sodium injection recalled due to temperature abuse during manufacturing
FDA (Drugs) · 2022-06-15
- SevereB. Braun Recalls Cefazolin Sodium Injectable Due to Particulate Matter
FDA (Drugs) · 2014-05-07
- CriticalB. Braun Recalls Cefazolin Sodium Injectable Due to Particulate Matter
FDA (Drugs) · 2014-05-07
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14